Viatris Inc.
USD15.56
-0.13 (-0.83%)
CEO
Scott Andrew Smith
IPO Date
1980-03-17
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$15.69
Prev. Close
$15.69
Day Low
$15.50
Day High
$15.72
52W Low
$8.44
52W High
$17.53
Market Cap
$18.12B
Volume
6.75M
| -23.4 |
| 31 Dec 2023 | FY | 41.7% | 0.4% | 0.3% | 0.1% | 0.90 | 1.67 | 237.6 |
| 31 Dec 2022 | FY | 40.0% | 12.8% | 9.9% | 4.2% | 0.91 | 1.58 | 6.5 |
| 31 Dec 2021 | FY | 31.2% | -7.1% | -6.2% | -2.3% | 1.05 | 1.10 | -12.9 |
| 31 Dec 2020 | FY | 31.8% | -5.6% | -2.9% | -1.1% | 1.14 | 1.22 | -16.8 |
| 31 Dec 2019 | FY | 33.9% | 0.1% | 0.1% | 0.1% | 1.07 | 1.21 | 617.0 |
| 31 Dec 2018 | FY | 35.0% | 3.1% | 2.9% | 1.1% | 1.14 | 1.39 | 40.0 |
| 31 Dec 2017 | FY | 40.2% | 5.8% | 5.2% | 1.9% | 1.10 | 1.13 | 33.1 |
| 31 Dec 2016 | FY | 42.4% | 4.3% | 4.3% | 1.4% | 1.39 | 1.49 | 40.8 |
| -22.5 |
| 30 Jun 2025 | Q2 | 37.2% | -0.1% | -0.0% | -0.0% | 0.95 | 1.37 | -569.3 |
| 31 Mar 2025 | Q1 | 35.7% | -93.5% | -19.4% | -7.9% | 0.92 | 1.68 | -0.9 |
| 31 Dec 2024 | Q4 | 34.4% | -14.6% | -2.8% | -1.2% | 0.77 | 1.65 | -7.2 |
| 30 Sept 2024 | Q3 | 39.0% | 2.5% | 0.5% | 0.2% | 0.89 | 1.51 | 36.5 |
| 30 Jun 2024 | Q2 | 39.3% | -8.6% | -1.7% | -0.7% | 0.88 | 1.53 | -9.7 |
| 31 Mar 2024 | Q1 | 41.1% | 3.1% | 0.6% | 0.2% | 0.90 | 1.67 | 31.3 |
| 31 Dec 2023 | Q4 | 42.1% | -20.0% | -3.7% | -1.6% | 0.89 | 1.57 | -4.2 |
| 30 Sept 2023 | Q3 | 42.9% | 8.4% | 1.6% | 0.7% | 0.88 | 1.60 | 8.9 |